Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes

NCT04816682 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Liver Diseases

Interventions

DRUG: Silymarin

Sponsor

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica